Jentadueto ® (linagliptin/metformin hydrochloride) tablets receive approval for the treatment of adults with Type 2 Diabetes in Europe

Jentadueto ® (linagliptin/metformin hydrochloride) tablets receive approval for the treatment of adults with Type 2 Diabetes in Europe
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news